Compare TBPH & AAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TBPH | AAT |
|---|---|---|
| Founded | 2013 | 1967 |
| Country | United States | United States |
| Employees | N/A | 208 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2013 | 2010 |
| Metric | TBPH | AAT |
|---|---|---|
| Price | $19.26 | $19.81 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 2 |
| Target Price | ★ $27.80 | $20.00 |
| AVG Volume (30 Days) | 386.5K | ★ 465.6K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | ★ 6.91% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.88 | ★ 0.92 |
| Revenue | $15,386,000.00 | ★ $436,204,000.00 |
| Revenue This Year | $70.90 | $5.01 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $21.66 | ★ $21.39 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.90 | $16.69 |
| 52 Week High | $21.03 | $22.79 |
| Indicator | TBPH | AAT |
|---|---|---|
| Relative Strength Index (RSI) | 45.07 | 64.75 |
| Support Level | $18.27 | $18.59 |
| Resistance Level | $19.04 | $20.47 |
| Average True Range (ATR) | 0.91 | 0.41 |
| MACD | -0.09 | 0.13 |
| Stochastic Oscillator | 23.72 | 95.66 |
Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.